BBOT
BridgeBio Oncology
BBOT
BBOT
67 hedge funds and large institutions have $514M invested in BridgeBio Oncology in 2026 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
32% less capital invested
Capital invested by funds: $756M → $514M (-$242M)
Holders
67
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$6.83M | |
| 2 | +$4.91M | |
| 3 | +$4.87M | |
| 4 |
AC
Armistice Capital
New York
|
+$3.52M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$3.45M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$15M | |
| 3 | -$10.7M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$5.81M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.92M |
